IN2014DN09410A - - Google Patents

Info

Publication number
IN2014DN09410A
IN2014DN09410A IN9410DEN2014A IN2014DN09410A IN 2014DN09410 A IN2014DN09410 A IN 2014DN09410A IN 9410DEN2014 A IN9410DEN2014 A IN 9410DEN2014A IN 2014DN09410 A IN2014DN09410 A IN 2014DN09410A
Authority
IN
India
Prior art keywords
proteomic profile
psg
fibronectin
expression
gestational diabetes
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivasa R Nagalla
Original Assignee
Diabetomics Llc
Srinivasa R Nagalla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabetomics Llc, Srinivasa R Nagalla filed Critical Diabetomics Llc
Publication of IN2014DN09410A publication Critical patent/IN2014DN09410A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/471Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN9410DEN2014 2012-04-13 2013-03-11 IN2014DN09410A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261623690P 2012-04-13 2012-04-13
PCT/US2013/030152 WO2013154709A1 (en) 2012-04-13 2013-03-11 Maternal biomarkers for gestational diabetes

Publications (1)

Publication Number Publication Date
IN2014DN09410A true IN2014DN09410A (enExample) 2015-07-17

Family

ID=49325612

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9410DEN2014 IN2014DN09410A (enExample) 2012-04-13 2013-03-11

Country Status (6)

Country Link
US (3) US8852873B2 (enExample)
EP (1) EP2836845B1 (enExample)
CN (1) CN104380112B (enExample)
ES (1) ES2684976T3 (enExample)
IN (1) IN2014DN09410A (enExample)
WO (1) WO2013154709A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160025737A1 (en) 2014-07-25 2016-01-28 Diabetomics, Llc Biomarkers for assessment of preeclampsia
US20180059122A1 (en) * 2015-03-20 2018-03-01 Iq Products B.V. Novel marker for gestational diabetes
CN106706928A (zh) * 2017-01-19 2017-05-24 深圳大学 一种妊娠期糖尿病的早期预测标志物及其检测方法
CN107024590A (zh) * 2017-03-13 2017-08-08 新疆医科大学 一种诊断1型和2型糖尿病的血清蛋白标志物组
CN113495150A (zh) * 2020-03-19 2021-10-12 首都医科大学附属北京世纪坛医院 尿液白蛋白及其多肽片段在妊娠糖尿病中的应用
CN113514634A (zh) * 2020-04-09 2021-10-19 武汉市朗典精医生物科技有限公司 制备检测Adipo/SHBG双指标免疫层析试剂盒
CN113804879A (zh) * 2020-06-15 2021-12-17 北京康美天鸿生物科技有限公司 幽门螺旋杆菌IgM和IgG抗体联合检测试剂盒
EP4428535A1 (en) * 2023-03-09 2024-09-11 Servizo Galego de Saude Diagnosis, monitoring or prognosis of diabetes or prediabetes

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855242A (en) 1986-04-14 1989-08-08 Joslin Diabetes Center, Inc. Method of detecting antibodies
DE3800048A1 (de) 1987-05-14 1988-11-24 Boehringer Mannheim Gmbh Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US5175085A (en) 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
EP0547164B1 (en) 1990-09-07 2004-06-09 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
US5512447A (en) 1990-09-07 1996-04-30 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
US5674978A (en) 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
DE4129849A1 (de) 1991-02-14 1992-08-27 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen humane pankreas-inselzellen
WO1992020811A2 (en) 1991-05-15 1992-11-26 Zymogenetics, Inc. Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5674692A (en) 1991-09-06 1997-10-07 Baekkeskov; Steinunn Methods for diabetes susceptibility assessment in asymptomatic patients
US5200318A (en) 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
EP0701569B1 (en) 1992-12-03 2008-11-12 The Regents Of The University Of California Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
ZA94845B (en) 1993-02-09 1994-11-11 Univ Monash Methods for the diagnosis of diabetes and prediabetic conditions
ATE221200T1 (de) 1993-04-16 2002-08-15 Univ California Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
US5547847A (en) 1993-09-07 1996-08-20 University Of Washington Diagnosis of insulin-dependent diabetes
US5561049A (en) 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5989551A (en) 1995-10-25 1999-11-23 The United States Of America As Represented By The Department Of Health And Human Services Materials and methods for detection and treatment of insulin-dependent diabetes
US6391651B1 (en) 1995-08-11 2002-05-21 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Materials and methods for detection of insulin dependent diabetes
US5821334A (en) 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
EP0929683A1 (en) 1996-03-06 1999-07-21 ZymoGenetics, Inc. DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE
US5670377A (en) * 1996-03-14 1997-09-23 Sansum Medical Research Foundation Method of diagnosing gestational diabetes
AUPO468597A0 (en) 1997-01-21 1997-02-13 Montech Medical Developments Pty Ltd Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
DE19839736A1 (de) 1998-09-01 2000-03-02 Roche Diagnostics Gmbh Humane monoklonale Antikörper gegen Inselzellantigen IA-2
ATE316653T1 (de) 2000-10-17 2006-02-15 Besst Test Aps Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
EP1386155A4 (en) 2001-04-10 2006-05-10 Univ Leland Stanford Junior THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES
AU2003237312A1 (en) 2002-05-29 2003-12-19 University Of Washington Mutants of gad65 and ian5 relating to diabetes
FR2847263B1 (fr) 2002-11-18 2006-01-13 Commissariat Energie Atomique Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
WO2004111608A2 (en) 2003-06-09 2004-12-23 Mcintyre John A Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
US7648825B2 (en) 2003-06-20 2010-01-19 University Of Florida Research Foundation, Inc. Biomarkers for differentiating between type 1 and type 2 diabetes
TW200508609A (en) 2003-07-15 2005-03-01 Bioarray Solutions Ltd Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
WO2005017192A2 (en) 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
SE0400683D0 (sv) * 2004-03-19 2004-03-19 Forskarpatent I Syd Ab Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
ATE534750T1 (de) * 2004-07-30 2011-12-15 Adeza Biomedical Corp Onkofetales fibronektin als zervixkarzinom-marker
WO2006032126A1 (en) 2004-09-24 2006-03-30 Syn X Pharma, Inc. Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
ITRM20050398A1 (it) 2005-07-26 2007-01-27 Gian Franco Bottazzo Metodo per la rilevazione di cellule t in pazienti neodiagnosticati per diabete di tipo 1.
US8691944B2 (en) * 2005-10-04 2014-04-08 The Research Foundation For The State University Of New York Fibronectin polypeptides and methods of use
WO2007062789A1 (en) 2005-11-29 2007-06-07 F. Hoffmann-La Roche Ag Fibronectin as target/marker for insulin resistance
US20090197286A1 (en) 2006-02-06 2009-08-06 Rappaport Family Institute For Research In The Med Methods and Kit for Diagnosing T1DM
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
PL2118309T3 (pl) 2006-12-29 2015-07-31 Univ Colorado Regents Cel diagnostyczny i terapeutyczny dla chorób autoimmunologicznych i jego zastosowania
US10167450B2 (en) 2007-02-21 2019-01-01 Sarl Endocells Human pancreatic beta cell lines for diagnostic of diabetes
EP2198304B1 (en) 2007-09-06 2016-01-13 University of Washington Molecules and methods for treatment and detection of diabetes
WO2009045403A2 (en) 2007-10-01 2009-04-09 The Board Of Trustees Of The Leland Stanford Junior University MENIN REGULATION OF β-ISLET CELL PROLIFERATION
US20100016173A1 (en) * 2008-01-30 2010-01-21 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009097579A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
WO2009099603A1 (en) 2008-02-04 2009-08-13 Women & Infants Hospital Serum-based, diagnostic, biological assay to predict pregnancy disorders
WO2010057647A2 (en) 2008-11-21 2010-05-27 Universita' Degli Studi Di Milano Methods and compositions for the diagnosis and treatment of diabetes
KR101067815B1 (ko) 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
WO2011085057A2 (en) 2010-01-06 2011-07-14 The Regents Of The University Of Colorado, A Body Corporate Methods for detecting insulin autoantibody
US8748352B2 (en) 2011-08-16 2014-06-10 Battelle Memorial Institute Peptide and protein biomarkers for type 1 diabetes mellitus

Also Published As

Publication number Publication date
ES2684976T3 (es) 2018-10-05
CN104380112A (zh) 2015-02-25
US8975034B2 (en) 2015-03-10
CN104380112B (zh) 2017-05-24
US20130274123A1 (en) 2013-10-17
US20150037822A1 (en) 2015-02-05
US8852873B2 (en) 2014-10-07
US20140080157A1 (en) 2014-03-20
EP2836845B1 (en) 2018-05-09
US9383370B2 (en) 2016-07-05
EP2836845A4 (en) 2015-11-18
EP2836845A1 (en) 2015-02-18
WO2013154709A1 (en) 2013-10-17

Similar Documents

Publication Publication Date Title
IN2014DN09410A (enExample)
Rodríguez-Suárez et al. Urine as a source for clinical proteome analysis: from discovery to clinical application
NZ707263A (en) A test device and method for identifying pregnancy based on hcg and lh levels in a sample
WO2014144129A3 (en) Biomarkers and methods for predicting preterm birth
ES2528321T3 (es) Detección de a-fucosilación en anticuerpos
WO2013052505A3 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
WO2009006323A3 (en) Methods and marker combinations for screening for predisposition to lung cancer
MX390227B (es) Dispositivo y metodo mejorados para prueba de embarazo.
WO2013188686A3 (en) Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
WO2014143977A3 (en) Biomarkers and methods for predicting preeclampsia
IL302061A (en) Prediction based on a model in a critically modeled filter bank
SG10201906981TA (en) Methods and reagents for the assessment of gestational diabetes
WO2013036754A3 (en) Methods and compositions for diagnosis of ovarian cancer
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2016198833A3 (en) Methods for analysing a urine sample
WO2008132753A3 (en) Methods and kits for detecting fetal cells in the maternal blood
MX2020010714A (es) Metodos para cuantificar la il-33.
EP3736571A4 (en) METHOD, REAGENT AND CHIP FOR MEASURING THE ANALYTE CONCENTRATION IN A BIOLOGICAL SAMPLE
Żurawicz et al. Analysis of amino acids in autism spectrum disorders
WO2013076579A3 (en) Method for assessing risk of bone fracture
NZ720608A (en) Β-glucan assay methods
ES2908615T3 (es) Método para determinar el riesgo de parto prematuro
WO2010059855A3 (en) Identification of biomarkers for screening and monitoring of prostate cancer and prostate related diseases
Leung et al. BOTH FIRST TRIMESTER CROWN RUMP LENGTH AND MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN A ARE INDEPENDENT PREDICTORS OF BIRTH WEIGHT
EP4495898A3 (en) Computer-implemented method of analysing data from measured values of characteristics of objects in samples